George K. Papadimas - Concepedia

Author

George K. Papadimas

Also Known As

ArgyroA Krase, G K Papadimas, G K. Papadimas, G Papadimas, G. K. Papadimas, G. Papadimas, G.K. Papadimas, GEORGIOS K. PAPADIMAS, GIORGOS PAPADIMAS, Gee Kim

139

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Eginition Hospital National and Kapodistrian University of Athens Children's Hospital Agia Sophia Institute of Child Health Medical University of Warsaw

About

George K. Papadimas is an author at Eginition Hospital specializing in medicine, pathology, and applied physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	387
2	Health Sciences	3	3	155
3	Allergy	2	2	53
4	Education	1	1	64
5	Natural Sciences	1	1	10

George K. Papadimas

Publications

830

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial Benedikt Schoser, Mark Roberts, Barry J. Byrne, The Lancet Neurology Clinical TrialsCipaglucosidase AlfaPharmacotherapyMedicineLate-onset Pompe Disease	2021	124
Effects of high‐intensity interval cycling performed after resistance training on muscle strength and hypertrophy Stavroula Tsitkanou, K. Spengos, Angeliki-Nikoletta Stasinaki, Scandinavian Journal of Medicine and Science in Sports Physical ActivityNeuromuscular CoordinationMuscle FunctionHigh-intensity Interval TrainingAerobic Exercise	2016	64
Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress Andrie Koutsoulidou, Tassos C. Kyriakides, George K. Papadimas, PLoS ONE	2015	63
Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy Gerasimos Terzis, Filippos Dimopoulos, George K. Papadimas, Molecular Genetics and Metabolism Physical ActivityEnzyme Replacement TherapyExercisePhysical FitnessExercise Physiology	2011	57
Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver George K. Papadimas, Konstantinos Tzirogiannis, Georgios I. Panoutsopoulos, Liver International	2006	51
Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study Marianela Schiava, Chiseko Ikenaga, Rocío N. Villar‐Quiles, Journal of Neurology Neurosurgery & Psychiatry	2022	37
Body composition analysis in late-onset Pompe disease George K. Papadimas, Gerasimos Terzis, Spyridon Methenitis, Molecular Genetics and Metabolism Body Composition AnalysisBody CompositionDisease MechanismDisease Progression	2010	36
Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress Andrie Koutsoulidou, Marinos Photiades, Tassos C. Kyriakides, Human Molecular Genetics Muscle FunctionPathologyExtracellular MicrovesiclesProgressive Muscle WastingMyotonic Dystrophy Patients	2017	34
The hepatoprotective effect of putrescine against cadmium-induced acute liver injury Konstantinos Tzirogiannis, Georgios I. Panoutsopoulos, Maria Demonakou, Archives of Toxicology InflammationHepatologyAllergyMedicineLiver Physiology	2004	30
Polyneuropathy induced by HIV disease and antiretroviral therapy Panagiotis Kokotis, Martin Schmelz, George K. Papadimas, Clinical Neurophysiology Antiretroviral TherapyTreatment And PreventionNeuropathic PainNeurologyHiv	2012	30

Page 1